Successful first closing of Series A2 financing round

07 March 2023

We are excited to announce the successful first closing of our A2 financing round!

This will allow us to accelerate our developments towards a full product suite that will help to better serve patients, sites, sponsors and regulatory agencies.

We are grateful to have the support of a strong group of investors who share PharmaTrail’s vision and the potential of blockchain as the new standard for ensuring data security, integrity, and transparancy in clinical trials.

PharmaTrail AG
Peter Merian-Strasse 90
CH-4052 Basel
This email address is being protected from spambots. You need JavaScript enabled to view it.

Member of